SCHEMBL4607826

SCHEMBL4607826

COc1cc2c(c(-c3cc(Cl)ccc3OC)c1)O[CH]C2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
HPGD P15428 4/20 0.39
KDM4E B2RXH2 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
USP2 O75604 1/20 0.38
PRNP P04156 1/20 0.38
PPARG P37231 1/20 0.38
MAPK10 P53779 1/20 0.38
NCOA2 Q15596 1/20 0.38
NCOA1 Q15788 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.36
NPC1 O15118 1/20 0.36
TSHR P16473 1/20 0.36
STAT3 P40763 1/20 0.36
RAB9A P51151 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5137212 0.91 HTR2A (0.42) ALDH1A1HPGDKDM4ENPSR1USP2
SCHEMBL4760683 0.89 CA12 (0.41) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL4770057 0.88 S1PR4 (0.37) ALDH1A1HPGDKDM4ENPSR1TDP1
SCHEMBL27723639 0.83 ALDH1A1 (0.42) ALDH1A1HPGDKDM4ENPSR1USP2
SCHEMBL5134380 0.79 CYP3A4 (0.40) ALDH1A1HPGDKDM4EHSD17B10TDP1
SCHEMBL27723628 0.78 HTR7 (0.41) ALDH1A1HPGDKDM4EUSP2HSD17B10
SCHEMBL4713089 0.77 HTR2C (0.40) ALDH1A1HPGDKDM4ENPSR1USP2
SCHEMBL4713088 0.76 HTR2C (0.40) ALDH1A1HPGDKDM4ENPSR1USP2
SCHEMBL4759176 0.75 MAPK14 (0.36) MAPT
SCHEMBL4768176 0.74 PTGS2 (0.39) ALDH1A1SMN1; SMN2NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007509174-A 2007-04-12 JP claimed
EP-1675840-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth a Corporation of the State of Delaware (US) 2006-07-05 EP claimed
WO-2005044812-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH A CORPORATION OF THE STATE OF DELAWARE (US) 2005-05-19 WO claimed
EP-1874292-A2 METHODS FOR MODULATING BLADDER FUNCTION Wyeth (US) 2008-01-09 EP disclosed
EP-1874750-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS Wyeth Incoporated (US) 2008-01-09 EP disclosed
EP-1871356-A1 DIHYDROBENZOFURAN DERIVATIVES AND USES THEREOF Wyeth a Corporation of the State of Delaware (US) 2008-01-02 EP disclosed
WO-2007030150-A1 DIHYDROBENZOFURANYL ALKANAMINE DERIVATIVES AS 5HT2C AGONISTS WYETH (US) 2007-03-15 WO disclosed
WO-2006116170-A1 DIHYDROBENZOFURAN DERIVATIVES AND USES THEREOF WYETH (US) 2006-11-02 WO disclosed
WO-2006116169-A2 METHODS FOR MODULATING BLADDER FUNCTION WYETH (US) 2006-11-02 WO disclosed